How to Treat Postnasal Drip

Written by Professor Vik Veer, Consultant ENT & Sleep Surgeon  ·  Published 20th September 2026  ·  Last reviewed 20th September 2026

Start Here: What to Do at Home

Before anyone reaches for antibiotics or surgery, there is a sequence of things that can be done at home. They are cheap, they are low-risk, and in a reasonable proportion of people they are sufficient on their own. The main reason they fail is that people abandon them after ten days. Nothing on this list works quickly.

1. High-volume saline nasal irrigation

This is not the same thing as a saline spray. A spray delivers roughly a tenth to a fifth of a millilitre and deposits most of it just inside the nostril. A high-volume irrigation delivers 240 ml, which actually passes through the nasal cavity and washes the drainage pathways. The difference in what reaches the back of the nose is not marginal.

The practical method: use a squeeze bottle such as a NeilMed Sinus Rinse, fill it with previously boiled and cooled water or distilled water (never straight from the tap), and add the sachet supplied with it so that the salt concentration is correct. Lean forward over a sink, keep your mouth open, and squeeze gently into one nostril so that the fluid runs out of the other. Once or twice a day.

I should be honest about the evidence base, because it is thinner than the enthusiasm for it suggests. The Cochrane review of saline irrigation in chronic sinus disease found only two randomised trials worth including, rated the evidence low to very low quality, and reported that around a quarter of people in the irrigation group had some side effect including nosebleeds ^[1]. A 2026 fragility analysis of the randomised trials found that most of the significant findings would reverse if only a handful of patients had responded differently ^[2]. What I would say in defence of it is that the intervention is nearly free, the risks are small and reversible, and in a condition where the alternative is repeated antibiotics, a treatment with modest evidence and negligible harm is a reasonable first move.

2. Saline gargling

This one is underused and I suspect it is underused because it sounds too simple. A Korean group studied people whose only symptom was postnasal drip, with no cough and no other nasal complaint, and treated them with normal saline oral gargling for twelve weeks. SNOT-22 and postnasal drip symptom scores both improved significantly ^[3].

Two important caveats. It was a retrospective review of records rather than a randomised trial, so there was no control group and no way to separate the treatment from the natural settling of symptoms over three months. And the most interesting finding in the paper was not the treatment effect at all. It was that there was no correlation between what the endoscope showed in the nasopharynx and how bad the patients said their symptoms were ^[3]. That finding runs through this entire page.

3. Steroid nasal spray, used properly

Most people who tell me a steroid spray did not work were using it incorrectly, using it for ten days, or both. The technique matters: spray with the opposite hand, aim outwards towards the eye on the same side rather than straight up or inwards at the septum, and do not sniff hard afterwards. Sniffing pulls the drug down the back of the throat where it does nothing.

Give it three to four weeks before judging it, and ideally irrigate first and spray afterwards so the drug is landing on a clean surface rather than on a layer of mucus. There is a small randomised trial suggesting that combination does better than medication alone, although it was a modest study in a Chinese-language journal and I would not lean on it heavily ^[4].

The correct spray technique, demonstrated — which hand, where to aim, and why sniffing afterwards wastes the dose.

4. Stop clearing your throat

This is the piece of advice patients most dislike and it is probably the most valuable thing on the page. Throat clearing traumatises the lining of the throat and the vocal cords. The lining responds to trauma by producing mucus. The mucus prompts more throat clearing. It is a genuinely self-sustaining loop, and a proportion of long-standing postnasal drip is largely this loop running on its own long after whatever started it has gone.

Instead of clearing your throat, take a sip of water, or swallow firmly, or do a silent effortful swallow. The urge does fade, but it takes a couple of weeks of consistent effort. See the section on hypersensitivity below for the formal version of this approach.

5. The things not to do

I would also be cautious about repeated antibiotic courses, antihistamines taken indefinitely in people who have no allergy, and the various mucus-thinning supplements sold online, for which there is essentially no controlled evidence in this condition.

"This doctor is not your typical doctor. He does not treat your symptom and guess what’s your health issues — he actually diagnoses you and tries to find the actual cause behind your problems. It sounds obvious, something that every doctor should do, but it’s not. I am honoured to have met Dr Vik Veer. I feel like we are actually doing steps towards recovering my sleep, rather than running blindly in the fog. I couldn’t recommend any other doctor more than him." Google Review, 5 stars — Michael Kolodziej

What Postnasal Drip Actually Is

The nose and sinuses produce somewhere in the region of a litre of mucus a day. Almost all of it is swept backwards by the cilia, the microscopic hairs lining the airway, and swallowed without anyone noticing. Postnasal drip is what happens when that process becomes noticeable, either because there is more mucus, because the mucus is thicker and moves badly, or because the throat has become better at detecting something that was always there.

In the respiratory literature the same problem, when it comes with a cough, is usually called upper airway cough syndrome. Confusingly, a large group of people have the dripping sensation without any cough at all, which is part of why the terminology has never settled.

There is no objective test. No scan measures postnasal drip. Endoscopy shows the state of the lining and any visible secretions, and it is genuinely useful for finding polyps, pus, a deviated septum or adenoid tissue, but it does not measure the symptom. Patient-reported scores such as the SNOT-22 are what get used in research and in clinic, which means the assessment rests largely on the history.

Working out which type you have

This table is a rough guide rather than a diagnostic tool, and the categories overlap far more often than a table suggests. Still, it is a reasonable starting point.

One point on mucus colour, since it comes up in every consultation. Yellow and green colour comes from myeloperoxidase, an enzyme released by white blood cells. It tells you the immune system is active. It does not tell you the infection is bacterial, and it certainly does not tell you that antibiotics will help. Ordinary viral colds produce green mucus routinely.

Infected and Stagnant Mucus: the Biofilm Problem

This is the group where postnasal drip comes with thick, discoloured, sometimes foul-tasting mucus, a sense of pressure behind the cheeks or forehead, and a history of repeated courses of antibiotics that help for a fortnight before everything returns.

What a biofilm is

Bacteria do not generally live as free-floating individuals on a mucosal surface. They organise themselves into a community and secrete a matrix of sugars, proteins and DNA that anchors them to the surface and shields them. That structure is a biofilm. Inside it the bacteria grow slowly, communicate chemically, and become dramatically less susceptible to antibiotics than the same organisms would be in a laboratory culture dish ^[5].

This is the explanation for a pattern almost every patient with chronic sinus disease will recognise. Swabs grow an organism, the antibiotic is chosen to match it, the patient improves, and then within weeks the symptoms return. The antibiotic cleared the free-floating bacteria and left the biofilm intact.

The evidence, including the parts that complicate it

Biofilms were first documented on sinus lining in chronic sinusitis in the mid-2000s. Using scanning electron microscopy, one study found biofilm in 24 of 30 patients undergoing sinus surgery and in none of four controls ^[6]. A second study found biofilm in 14 of 18 patients, with Haemophilus influenzae, Streptococcus pneumoniae and Staphylococcus aureus predominating, and made the important observation that the organisms cultured from the sinus fluid frequently did not match the organisms identified within the biofilm ^[7].

Two findings temper the enthusiasm. First, that same study found biofilm on two of its five healthy control samples, which raises the possibility that in some people biofilm is simply a coloniser rather than the cause of anything ^[7]. Second, a larger study of 518 patients found that the ability to form biofilm in vitro was not associated with polyps, allergy, smoking or age, although it was associated with previous sinus surgery ^[8].

Where the evidence is stronger is on prognosis. Biofilm presence was strongly associated with persistent inflammation after sinus surgery, in one series affecting 53 per cent of biofilm-positive patients and none of the biofilm-negative ones ^[9]. Biofilm-forming Pseudomonas aeruginosa and Staphylococcus aureus were associated with worse outcomes a year after surgery ^[10]. So whatever biofilm does or does not initiate, its presence predicts a harder course.

What actually shifts it

Mechanical washing is the mainstay. Not glamorous, but disrupting the matrix physically and diluting the secretions is the most reliable thing available outside the operating theatre. This is the strongest single argument for high-volume irrigation rather than sprays.

Steroid irrigation rather than steroid spray is worth discussing with your specialist if sinus inflammation is confirmed. Adding budesonide to the 240 ml rinse delivers far more drug to the relevant surfaces than a spray does, and the long-term safety data on cortisol suppression are reassuring. I have set out the method, the dose and the safety evidence in detail on the sinusitis page, along with the endotyping approach that decides which patients it suits.

Additives to the rinse. Xylitol is the most studied. A small randomised crossover pilot in 20 patients found better SNOT-20 scores on xylitol than on saline, although only 15 returned usable data and the difference was a couple of points ^[11]. A larger crossover study of 100 patients after nasal surgery found modest advantages, particularly for rhinorrhoea in allergic patients ^[12]. Manuka honey kills staphylococcal and pseudomonal biofilms convincingly in a dish ^[13][14], but in-vitro killing has repeatedly failed to translate into clinical benefit in this field, and I would not currently recommend it. Povidone-iodine rinses after sinus surgery gave no advantage over plain saline in a randomised trial ^[15].

Surgery. When the sinuses are genuinely obstructed, opening the drainage pathways is the treatment that changes the mechanics. One trial of 200 patients found that adding functional endoscopic sinus surgery to septal and turbinate surgery significantly reduced postnasal drip at six months compared with the septal and turbinate surgery alone ^[19], and the MACRO trial found surgery substantially better than medical treatment for chronic rhinosinusitis overall ^[17]. What the operation involves is described here. The caveat is that surgery treats obstruction, not the inflammatory process that caused it, so irrigation continues afterwards rather than stopping.

N-acetylcysteine breaks the disulphide bonds that make mucus crusts stiff. A single-blind randomised trial of 49 patients found better postnasal drip visual analogue scores two weeks after sinus surgery when it was added to the rinses ^[20]. Small, short, and specific to the post-operative setting, but biologically sensible and low risk.

Other Treatments and What the Evidence Shows

This section covers the things that get tried when the obvious measures have not worked. I have put the study size and design next to each one, because in this field the gap between what is widely recommended and what has actually been tested properly is unusually wide.

The general shape of this evidence is worth naming plainly. Almost every positive study in postnasal drip is either small, unblinded, short, or measuring a secondary outcome. The exceptions are the posterior nasal nerve trials and the MACRO surgical trial. When the evidence is this thin, the argument for starting with the cheapest and safest options is not caution for its own sake. It is that we genuinely do not know enough to justify starting anywhere else.

Reflux, Pepsin and Laryngopharyngeal Reflux

A substantial group of people with postnasal drip have no sinus disease at all on scanning and no allergy, and the drip is coming from the other direction. Instead of mucus falling down from the nose, irritant material is arriving upwards from the stomach.

The mechanism

Laryngopharyngeal reflux, or LPR, describes stomach contents reaching the throat and voice box. The lining there has none of the protective adaptations of the oesophagus, so it tolerates the exposure badly. The important agent is often not acid at all but pepsin, the main protein-digesting enzyme of the stomach ^[29].

Pepsin matters for two reasons. It is taken up into the cells lining the throat and voice box, where it can continue to cause inflammation long after the reflux episode itself has finished. And it can be activated by acid arriving later, which means a non-acidic reflux episode can still cause damage ^[29]. This is the likeliest explanation for a very familiar clinical situation: a patient on a high dose of a proton pump inhibitor whose heartburn has entirely resolved and whose throat symptoms have not shifted at all. Acid suppression does nothing about pepsin already present in the tissue.

Pepsin has been measured in saliva and in nasal washings in people with reflux-related throat symptoms, and levels correlate with symptom scores ^[30]. However, repeated measurements in the same patient vary considerably depending on the time of day and the sample, which limits its usefulness as a test ^[31].

An important caution about diagnosis

Where symptoms persist, or where the throat symptoms occur without any heartburn or indigestion, the consensus recommends objective testing with 24-hour pH-impedance monitoring or 96-hour wireless pH monitoring before escalating treatment ^[32]. The absence of a diagnostic gold standard is the central difficulty in this whole area ^[33].

Treatment

Lifestyle and dietary measures come first, and they are more effective than their dull reputation suggests. Nothing to eat for three hours before lying down. Raise the head of the bed by 10 to 15 cm at the frame or with blocks, rather than piling up pillows, which bends the neck and achieves little. Reduce alcohol, late-evening caffeine, and if you smoke, stopping helps more than any medication on this list. A multicentre study of dietary modification combined with mucosal protectant preparations found significant falls in salivary and nasal pepsin concentrations ^[34].

Alginate preparations such as Gaviscon Advance taken after meals and at bedtime form a physical raft over the stomach contents. They are a reasonable first medication, cheap, available without prescription, and they act on non-acidic reflux in a way that acid suppression does not.

Proton pump inhibitors. Two small randomised trials support them specifically for postnasal drip. Rabeprazole 20 mg twice daily for 90 days in 47 patients without sinus disease significantly reduced the frequency of postnasal drip symptoms compared with placebo ^[35]. Ilaprazole 20 mg daily for eight weeks in 80 patients with LPR significantly reduced the postnasal drip component of the Reflux Symptom Index ^[36]. Both are small, and the wider literature on PPIs for throat symptoms is considerably less encouraging than for heartburn. My practical position is that a properly dosed trial of eight to twelve weeks, taken half an hour before food rather than with it, is reasonable where the history fits. If it has not helped by then, the answer is to stop it and reconsider the diagnosis, not to double the dose.

Potassium-competitive acid blockers, a newer class producing faster and more sustained acid suppression, appear to match high-dose PPIs for throat symptoms and may do better in severe cases ^[37]. They are not yet routinely available in the UK for this indication.

Surgery for reflux is a long way down the list and belongs to the gastroenterologists and upper GI surgeons rather than to me. Fundoplication reduces Reflux Symptom Index scores in selected patients at two years ^[38], but the selection has to be right, and patients whose throat symptoms turn out to be hypersensitivity rather than reflux do badly with it.

Treating Postnasal Drip Caused by Rhinitis

Rhinitis simply means inflammation of the nasal lining. It splits into allergic rhinitis, where an identifiable trigger such as pollen, dust mite or animal dander sets off the immune system, and non-allergic rhinitis, where the same symptoms occur with entirely negative allergy testing and the trigger tends to be cold air, strong smells, spicy food, alcohol or exercise. Both produce drip, and the non-allergic form responds poorly to antihistamines, which is a common source of frustration.

Topical treatment

Steroid nasal sprays remain the foundation. A meta-analysis of 16 randomised trials involving 2,267 patients found intranasal corticosteroids better than oral antihistamines for postnasal drip ^[39]. I will note the effect size honestly: a standardised mean difference of -0.24, with a confidence interval running from -0.42 to -0.06. That is a small effect, and the interval only just clears zero. A systematic review looking specifically at secondary sinonasal symptoms such as drip found the results across individual trials inconsistent ^[40]. Steroid sprays are the right starting point, but they are not usually the whole answer for drip on their own.

Ipratropium bromide nasal spray blocks the muscarinic receptors that drive watery secretion, and it is genuinely useful for a streaming nose. A meta-analysis of nine randomised trials in 1,920 patients confirmed the benefit for rhinorrhoea, but found the effect on postnasal drip specifically less consistent, and noted that nosebleeds were roughly twice as common (relative risk 2.19, 95% confidence interval 1.22 to 3.93) ^[41]. It is worth trying, particularly for a watery non-allergic drip, but with that trade-off in mind.

Combination regimens of a steroid, ipratropium and a topical antihistamine such as azelastine have been studied over 28 days in a small open trial of 21 patients, with improvement in cough and anterior discharge and a downward trend in drip scores that did not reach significance ^[42]. Small and unblinded, but it reflects what tends to happen in practice, which is that one agent alone is often insufficient.

Saline irrigation as an adjunct to those medications was tested in a randomised trial of 58 patients with allergic rhinitis and postnasal drip, reporting an effective rate of 89.7 per cent with irrigation added versus 58.6 per cent with medication alone ^[4]. A striking difference, though from a single small study.

Posterior nasal nerve ablation

Where medication genuinely fails, this is the intervention with the best evidence of anything in this entire field. The posterior nasal nerve carries the parasympathetic fibres that instruct the nasal glands to secrete. Interrupting them reduces the secretory signal.

The historical version of this operation, vidian neurectomy, worked but carried real risks of a numb palate and a dry eye, because the same nerve bundle carries fibres to the tear gland ^[43]. The modern approach targets the posterior nasal nerve further downstream, which spares the lacrimal fibres, and it is done endoscopically through the nose under local or general anaesthetic using radiofrequency energy or cryotherapy.

The numbers:

• In a pooled cohort of 228 patients, median postnasal drip scores fell from 3 (severe) to 1 at six months ^[23].
• A meta-analysis of 1,408 patients found temperature-controlled radiofrequency neurolysis produced 31.6 per cent greater improvement in postnasal drip than turbinate reduction alone ^[24].
• A randomised sham-controlled trial, which is the design that matters most here given how responsive this symptom is to placebo, found a drip score reduction of 1.1 with active treatment against 0.3 with sham ^[25].
• Benefit appears durable, with sustained reductions reported at two and three years across several multicentre cohorts ^[44][45][46].
• In one prospective series, 61.7 per cent of patients had stopped or reduced their rhinitis medication two years afterwards ^[44].
• In medically refractory patients, around 72.5 per cent achieved at least a 30 per cent improvement, and this did not depend on whether they had previously responded to ipratropium ^[47].

Two honest qualifications. Most of these studies have been conducted or funded in the context of commercial device development, which is normal in surgical innovation but does affect how one reads consistently positive results. And it treats secretion, so it will not help a patient whose drip is actually reflux or hypersensitivity. Patient selection is everything, which is the argument for endoscopic assessment before committing to any procedure.

When the Problem Is the Sensation, Not the Mucus

This is the group that gets missed, and it is not small. These are people who have had every spray, several antibiotic courses, a normal CT scan, negative allergy tests and often a trial of a PPI, and who still feel mucus at the back of the throat constantly.

What has happened in many of them is that the sensory nerves supplying the throat and voice box have become hypersensitive, often after a viral infection or a prolonged period of inflammation. This is the same process recognised in chronic cough as cough hypersensitivity syndrome, and it has genuine parallels with chronic pain, where the nervous system continues to report a problem after the original injury has healed ^[48]. Innocuous triggers such as talking, cold air, perfume or a dry room set it off. The amount of mucus is normal. The reporting is not.

Recall the finding from the gargling study: in patients whose only symptom was postnasal drip, endoscopic appearances did not correlate with symptom severity at all ^[3]. That is precisely what you would expect if a proportion of these patients have a sensory problem rather than a secretory one.

What helps

Adding more medication does not. What does help is behavioural retraining delivered by a speech and language therapist, and the evidence for it is better than for most of the drugs on this page.

A randomised placebo-controlled trial in 87 patients with chronic cough found clinically successful outcomes in 88 per cent of the treatment group against 14 per cent of the placebo group ^[49]. A multicentre randomised trial of a combined physiotherapy and speech therapy intervention in 75 patients improved cough-related quality of life and reduced objectively measured cough frequency by 41 per cent, with benefit sustained to three months ^[50]. In a series of 65 patients with chronic throat symptoms referred for reflux assessment, 85 per cent responded to laryngeal recalibration therapy, and the response rate was essentially the same whether or not reflux was actually proven on testing ^[51]. That last finding is the one I would ask people to sit with.

The treatment involves education about the mechanism, laryngeal hygiene and hydration, deliberate suppression of the urge to clear the throat, breathing exercises, and counselling around the anxiety that a constant throat symptom generates. It takes four to six sessions. In refractory cases, neuromodulator medications such as gabapentin or pregabalin can be added, although side effects limit their use ^[52].

When to See a Specialist

Postnasal drip is common and rarely dangerous, but a few features warrant assessment rather than another spray.

• One-sided symptoms. Persistent discharge or blockage on one side only needs examining, particularly if it is blood-stained.
• Blood in the mucus repeatedly, rather than the occasional streak after vigorous nose-blowing.
• Loss of smell, which points towards polyps or type 2 inflammation and changes the treatment substantially. See the anosmia page.
• Persistent facial pain or pressure with discoloured discharge, particularly if it worsens after apparently improving.
• Difficulty swallowing, persistent hoarseness beyond three weeks, or unexplained weight loss. These need prompt assessment for reasons unrelated to postnasal drip.
• Symptoms that have not improved after eight weeks of consistent saline irrigation, correct steroid spray technique and stopping throat clearing.

What an assessment adds is mainly the ability to tell these mechanisms apart. A nasendoscopy, which takes a couple of minutes in clinic, will identify polyps, pus, adenoid tissue, a septal deviation or a normal-looking nose, and that last finding is as informative as the others. Depending on the picture, a CT scan of the sinuses, allergy testing, or referral for pH-impedance monitoring may follow. The aim is to stop treating the wrong mechanism, which is the most common reason this symptom persists for years.

Related pages that may be useful: Sinusitis and Nasal Polyps, Blocked Nose, Hay Fever and Allergic Rhinitis, and Stopping Decongestant Nasal Sprays.

"Mr Veer is without doubt the best doctor to deal with sleep apnoea and your breathing issues if impacted by your nose, tonsils, or anything else in his expertise as an ENT specialist. Very professional and transparent." Google Review, 5 stars — Rogier Quirijns

References

1. Chong LY et al. Saline irrigation for chronic rhinosinusitis. Cochrane Database of Systematic Reviews. 2016. Two randomised trials, 116 participants; large-volume hypertonic saline better than usual care, evidence rated low to very low quality; 23% of the saline group reported side effects.
2. Sethi R et al. The statistical fragility of saline nasal irrigation for rhinosinusitis: a systematic review. The Laryngoscope. 2026. Eight randomised trials, 38 dichotomous outcomes; median fragility index 5.
3. Joo Y, Kim HJ, Jeon YJ, Kim SW. Postnasal drip syndrome: a new definition and successful oral gargling treatment. American Journal of Otolaryngology. 2025;46(4):104617. Retrospective cohort; 12 weeks of normal saline gargling; significant improvement in SNOT-22 and postnasal drip symptom scores; no correlation between endoscopic findings and symptom scores.
4. Lan YL, Tu XM. The efficacy of nasal irrigation as adjuvant treatment of allergic rhinitis with postnasal drip symptoms. 2014. Randomised trial, 58 patients; 89.7% effective rate with added irrigation versus 58.6% with medication alone.
5. Huang YL et al. The mechanisms of biofilm antibiotic resistance in chronic rhinosinusitis: a review. Medicine. 2022. Review of biofilm structure, quorum sensing and antibiotic resistance mechanisms.
6. Sanclement JA et al. Bacterial biofilms in surgical specimens of patients with chronic rhinosinusitis. The Laryngoscope. 2005. Scanning electron microscopy; biofilm in 24 of 30 patients, none of 4 controls.
7. Sanderson AR et al. Bacterial biofilms on the sinus mucosa of human subjects with chronic rhinosinusitis. The Laryngoscope. 2006. Fluorescent in situ hybridisation; biofilm in 14 of 18 patients but also in 2 of 5 controls; cultured organisms frequently did not match the biofilm organisms.
8. Zhang Z et al. Clinical factors associated with bacterial biofilm formation in chronic rhinosinusitis. Otolaryngology–Head and Neck Surgery. 2011. Cross-sectional study, 518 patients; biofilm formation associated with positive cultures and previous sinus surgery but not with polyps, allergy or age.
9. Hochstim CJ et al. Biofilm and persistent inflammation in endoscopic sinus surgery. Otolaryngology–Head and Neck Surgery. 2010. 24 patients; persistent mucosal inflammation in 53% of biofilm-positive versus 0% of biofilm-negative patients.
10. Bendouah Z et al. Biofilm formation by Staphylococcus aureus and Pseudomonas aeruginosa is associated with an unfavorable evolution after surgery for chronic sinusitis and nasal polyposis. Otolaryngology–Head and Neck Surgery. 2006.
11. Weissman JD et al. Xylitol nasal irrigation in the management of chronic rhinosinusitis: a pilot study. The Laryngoscope. 2011. Randomised double-blind crossover pilot, 20 subjects, 15 with analysable data; SNOT-20 fell 2.43 points on xylitol and rose 3.93 on saline (p = 0.044).
12. Kim DH et al. Effect of postoperative xylitol nasal irrigation on patients with sinonasal diseases. Otolaryngology–Head and Neck Surgery. 2018. Double-blind randomised crossover study, 100 patients after sinus or septal surgery.
13. Alandejani T et al. Effectiveness of honey on Staphylococcus aureus and Pseudomonas aeruginosa biofilms. Otolaryngology–Head and Neck Surgery. 2009. In vitro study only.
14. Jervis-Bardy J et al. Methylglyoxal-infused honey mimics the anti-Staphylococcus aureus biofilm activity of manuka honey. The Laryngoscope. 2011. In vitro study only.
15. Wu PH et al. Efficacy of povidone-iodine nasal irrigation solution after sinonasal surgery: a randomized controlled study. The Laryngoscope. 2021. 55 patients; no advantage over normal saline at three months.
16. Wallwork B et al. A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis. The Laryngoscope. 2006. Roxithromycin 150 mg daily for 12 weeks; benefit concentrated in patients with normal IgE.
17. Philpott C et al. The clinical effectiveness of clarithromycin versus endoscopic sinus surgery for adults with chronic rhinosinusitis with and without nasal polyps (MACRO): a pragmatic, multicentre, three-arm, randomised, placebo-controlled phase 4 trial. Lancet. 2025. 514 patients across 20 UK sites; surgery significantly better than both clarithromycin and placebo; clarithromycin not significantly better than placebo (adjusted mean difference -3.11, 98.33% CI -8.56 to 2.33).
18. El-Shinnawi M et al. Management of persistent postnasal drip without sinus affection. American Journal of Interdisciplinary Research and Innovation. 2024. Randomised trial, 50 patients; clarithromycin 250 mg daily for 12 weeks reduced throat clearing and mucus sensation.
19. Niazi SA et al. Efficacy of functional endoscopic sinus surgery in treatment of postnasal drip as an ancillary procedure: a comparative study. Pakistan Armed Forces Medical Journal. 2021. Quasi-experimental trial, 200 patients; significantly lower postnasal drip at six months when FESS was added (p < 0.003).
20. Wee J et al. Sinus irrigation with N-acetylcysteine after endoscopic sinus surgery for chronic rhinosinusitis: a preliminary report of a single-blind randomized controlled trial. Diagnostics. 2024. 49 patients; improved postnasal drip visual analogue scores at two weeks (p = 0.041).
21. Cheong T, Choi IS. Clinical aspects of chronic idiopathic postnasal drip: an entity not to be overlooked. In Vivo. 2024;38:2058-63. Observational cohort, 81 patients; 71.6% positive subjective response to first-generation antihistamine-decongestant combination; 25.9% recurrence.
22. Deeva Y et al. Clinical efficacy and safety of high-dose ambroxol in the form of oromucosal spray in postnasal drip syndrome: results of a multicenter study in Ukraine. Medicni Perspektivi. 2025. Prospective multicentre trial, 1,867 patients; substantial fall in postnasal drip severity score by day 5 (p < 0.001). Uncontrolled.
23. Gorelik D et al. Postnasal drip and chronic cough in patients with chronic rhinitis treated with temperature-controlled radiofrequency neurolysis. International Forum of Allergy & Rhinology. 2023. Pooled prospective analysis, 228 patients; median postnasal drip score fell from 3 to 1 at six months (p < 0.001).
24. Ripp AT et al. Surgical treatment outcomes in the management of rhinitis: a systematic review and meta-analysis. Annals of Otology, Rhinology & Laryngology. 2025. 1,408 patients; 31.6% greater improvement in postnasal drip with radiofrequency neurolysis than turbinate reduction alone (p < 0.0001).
25. Takashima M et al. Impedance-controlled multipoint radiofrequency ablation for chronic rhinitis: a randomized controlled trial. International Forum of Allergy & Rhinology. 2026. Sham-controlled; drip reduction -1.1 with active treatment versus -0.3 with sham (p < 0.001).
26. Stepanova V et al. Potential applications of botulinum toxin formulations in addressing postnasal syndrome. Russian Rhinology. 2024. Review of preliminary work.
27. La Mantia I et al. Salso-bromo-iodine thermal water: a nonpharmacological alternative treatment for postnasal drip-related cough in children with upper respiratory tract infections. Journal of Biological Regulators and Homeostatic Agents. 2019. Randomised single-blind trial, 140 children.
28. Ye K, Dai QB. Clinical observation on moxibustion at Baihui plus tuina for children with postnasal drip syndrome. Journal of Acupuncture and Tuina Science. 2022. See also Cui J et al. Chinese herbal therapy in the management of rhinosinusitis: a systematic review and meta-analysis. PLOS ONE. 2022, which notes inadequate study design and reporting across the majority of included trials.
29. Li Y et al. Effects of acids, pepsin, bile acids, and trypsin on laryngopharyngeal reflux diseases: physiopathology and therapeutic targets. European Archives of Oto-Rhino-Laryngology. 2021.
30. Klimara MJ et al. Correlation of salivary and nasal lavage pepsin with MII-pH testing. The Laryngoscope. 2020.
31. Lechien JR, Bobin F. Variability and accuracy of multiple saliva pepsin measurements in laryngopharyngeal reflux patients. Journal of Otolaryngology – Head & Neck Surgery. 2023.
32. Yadlapati RH et al. The San Diego consensus for laryngopharyngeal symptoms and laryngopharyngeal reflux disease. American Journal of Gastroenterology. 2025. 28-member international interdisciplinary working group; laryngoscopic findings alone cannot diagnose laryngopharyngeal reflux disease; ambulatory reflux monitoring required where symptoms are isolated or persistent.
33. Krause AJ et al. Diagnosis and management of laryngopharyngeal reflux. Alimentary Pharmacology & Therapeutics. 2024.
34. Gelardi M et al. Efficacy of dietary modifications and mucosal protectors in the treatment of laryngopharyngeal reflux: a multicenter study. Frontiers in Medicine. 2025.
35. Pawar S et al. Treatment of postnasal drip with proton pump inhibitors: a prospective, randomized, placebo-controlled study. American Journal of Rhinology & Allergy. 2007;21:695-701. 47 patients without sinonasal disease; rabeprazole 20 mg twice daily for 90 days significantly reduced symptom frequency (p = 0.018).
36. Lee JY et al. Effects of a proton-pump inhibitor on postnasal drip symptoms in patients with laryngopharyngeal reflux. Journal of Rhinology. 2023;30:139-43. 80 patients; ilaprazole 20 mg daily for eight weeks (p = 0.012).
37. Kim GH, Fass R. Potassium-competitive acid blockers for treatment of extraesophageal symptoms and signs. Journal of Neurogastroenterology and Motility. 2025.
38. Paranyak M, Patel R. A prospective randomized trial on laparoscopic total versus partial fundoplication in patients with atypical symptoms of gastroesophageal reflux disease. Langenbeck's Archives of Surgery. 2023. Median Reflux Symptom Index fell from over 21 to 10.4-11.6 at 24 months.
39. Weiner JM, Abramson M, Puy R. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials. BMJ. 1998;317:1624-9. 16 trials, 2,267 patients; postnasal drip standardised mean difference -0.24 (95% CI -0.42 to -0.06).
40. Deot N et al. Effect of intranasal corticosteroids on secondary sinonasal symptoms: a systematic review of randomized trials. American Journal of Rhinology & Allergy. 2019.
41. Pang JC et al. Intranasal anticholinergics for treatment of chronic rhinitis: systematic review and meta-analysis. The Laryngoscope. 2022. 9 trials, 1,920 patients; rhinorrhoea improved, postnasal drip benefit less consistent; epistaxis relative risk 2.19 (95% CI 1.22-3.93).
42. Macedo P et al. Postnasal drip and chronic cough: an open interventional study. Respiratory Medicine. 2009;103:1700-5. 21 patients, 28 days of fluticasone nasules with ipratropium and azelastine.
43. Yu AJ et al. Radiofrequency neurolysis of the posterior nasal nerve: a systematic review and meta-analysis. The Laryngoscope. 2023. See also Ehmer D et al. Temperature-controlled radiofrequency neurolysis for the treatment of rhinitis. American Journal of Rhinology & Allergy. 2021.
44. Ehmer D et al. Long-term outcomes following temperature-controlled radiofrequency neurolysis for the treatment of chronic rhinitis. Allergy & Rhinology. 2022. 61.7% had stopped or reduced rhinitis medication at two years.
45. Lee JT et al. Three-year outcomes after temperature-controlled radiofrequency ablation of the posterior nasal nerve for chronic rhinitis. American Journal of Rhinology & Allergy. 2025;39:398-409.
46. Ow RA et al. 3-year outcomes of temperature-controlled radiofrequency ablation of the posterior nasal nerve in patients with chronic rhinitis. International Forum of Allergy & Rhinology. 2025;15:915-25.
47. Dhanda AK et al. Posterior nasal nerve ablation as a viable treatment option for the primary symptom of postnasal drip. American Journal of Rhinology & Allergy. 2024;38:245-50. At least 30% subjective improvement in 72.5% of medically refractory patients.
48. Chung KF et al. Cough hypersensitivity and chronic cough. Nature Reviews Disease Primers. 2022.
49. Vertigan AE et al. Efficacy of speech pathology management for chronic cough: a randomised placebo controlled trial of treatment efficacy. Thorax. 2006. 87 patients; successful outcome in 88% of the treatment group versus 14% of the placebo group (p < 0.001).
50. Chamberlain Mitchell SAF et al. Physiotherapy, and speech and language therapy intervention for patients with refractory chronic cough: a multicentre randomised control trial. Thorax. 2016. 75 patients; Leicester Cough Questionnaire improved by 1.53 points (95% CI 0.21 to 2.85); cough frequency reduced by 41%.
51. Walsh E et al. Laryngeal recalibration therapy improves laryngopharyngeal symptoms in patients with suspected laryngopharyngeal reflux disease. American Journal of Gastroenterology. 2024. 65 patients; 85% symptom response, similar whether or not reflux was proven on testing.
52. Vertigan AE et al. Pregabalin and speech pathology combination therapy for refractory chronic cough: a randomized controlled trial. Chest. 2016. 40 patients. See also Morice AH et al. ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. European Respiratory Journal. 2019.

Contact Professor Vik Veer

If you would like an assessment of persistent postnasal drip, or a second opinion on treatment that has not worked, please use the details below.

Private secretary: 0207 458 4584

Email: secretary@consultant-surgeon.co.uk

Page created 20th September 2026 by Professor Vik Veer, Consultant ENT & Sleep Surgeon, 150 Harley Street, London. This page is patient education and does not replace individual medical assessment. Do not start or stop prescribed medication on the basis of a web page. Persistent one-sided symptoms, blood-stained discharge, difficulty swallowing, hoarseness beyond three weeks or unexplained weight loss should be assessed promptly. Patient comments are genuine published reviews; individual results vary.